CymitQuimica logo

Semustine

Ref. 3D-FS153233

250mg
Discontinued
500mg
Discontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .

Semustine
Biosynth

    Product Information

    Name:Semustine
    Brand:Biosynth
    Description:Semustine is an anti-cancer drug that belongs to the class of alkylating agents. It is a prodrug that is activated in the body by hydrolysis to the active form, methyl-CCNU. The drug has minimal toxicity and can be used as a model system for studying other anti-cancer drugs. Semustine has been shown to have minimal toxicity when administered orally or intravenously and has been used in experimental models of cancer. The drug also binds to DNA, forming covalent linkages with guanine bases, which prevents DNA synthesis and replication. Semustine is also a synthetic retinoid that can bind to specific regions of human serum albumin (HSA) and inhibit HSA function, which may be responsible for some of its toxic effects on humans.
    Notice:Our products are intended for lab use only. For any other use, please contact us.

    Chemical properties

    Molecular weight:247.72 g/mol
    Formula:C10H18ClN3O2
    Purity:Min. 95%
    InChI:InChI=1S/C10H18ClN3O2/c1-8-2-4-9(5-3-8)12-10(15)14(13-16)7-6-11/h8-9H,2-7H2,1H3,(H,12,15)
    InChI key:InChIKey=FVLVBPDQNARYJU-UHFFFAOYSA-N
    SMILES:CC1CCC(NC(=O)N(CCCl)N=O)CC1

    Inquiry about discontinued product: Semustine

    ◻️
    CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
    * Mandatory fields.